{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:17:18Z","timestamp":1776262638382,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Canterbury Bowel and liver trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10151-016-1578-4","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T01:17:30Z","timestamp":1483924650000},"page":"119-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The long-term outcome of anti-TNF alpha therapy in perianal Crohn\u2019s disease"],"prefix":"10.1007","volume":"21","author":[{"given":"J.","family":"Rayen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"Gearry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Frizelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Eglinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"1578_CR1","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus","year":"2004","unstructured":"Loftus EV (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126:1504\u20131517","journal-title":"Gastroenterology"},{"key":"1578_CR2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","volume":"55","author":"TW Eglinton","year":"2012","unstructured":"Eglinton TW, Barclay ML, Gearry RB, Frizelle FA (2012) The spectrum of perianal Crohn\u2019s disease in a population-based cohort. Dis Colon Rectum 55:773","journal-title":"Dis Colon Rectum"},{"key":"1578_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/eci.09.76","volume":"6","author":"TW Eglinton","year":"2010","unstructured":"Eglinton TW, Gearry RB (2010) Clinical factors predicting disease course in Crohn\u2019s disease. Expert Rev Clin Immunol 6:41\u201345","journal-title":"Expert Rev Clin Immunol"},{"key":"1578_CR4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0016-5085(98)70420-2","volume":"114","author":"A Lapidus","year":"1998","unstructured":"Lapidus A, Bernell O, Hellers G, L\u00f6fberg R (1998) Clinical course of colorectal Crohn\u2019s disease: a 35-year follow-up study of 507 patients. Gastroenterology 114:1151\u20131160","journal-title":"Gastroenterology"},{"key":"1578_CR5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cgh.2006.06.021","volume":"4","author":"LY Tang","year":"2006","unstructured":"Tang LY, Rawsthorne P, Bernstein CN (2006) Are perineal and luminal fistulas associated in Crohn\u2019s disease? A population-based study. Clin Gastroenterol Hepatol 4:1130\u20131134","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1578_CR6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/ibd.20190","volume":"13","author":"RB Gearry","year":"2007","unstructured":"Gearry RB, Roberts RL, Burt MJ et al (2007) Effect of inflammatory bowel disease classification changes on NOD2 genotype\u2013phenotype associations in a population-based cohort. Inflamm Bowel Dis 13:1220\u20131227","journal-title":"Inflamm Bowel Dis"},{"key":"1578_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s003840050052","volume":"11","author":"FA Frizelle","year":"1996","unstructured":"Frizelle FA, Santoro GA, Pemberton JH (1996) The management of perianal Crohn\u2019s disease. Int J Colorectal Dis 11:227\u2013237","journal-title":"Int J Colorectal Dis"},{"key":"1578_CR8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.51.3.362","volume":"51","author":"SJH Deventer Van","year":"2002","unstructured":"Van Deventer SJH (2002) Anti-tumour necrosis factor therapy in Crohn\u2019s disease: where are we now? (therapy update). Gut 51:362","journal-title":"Gut"},{"key":"1578_CR9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR et al (2002) Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet 359:1541\u20131549","journal-title":"Lancet"},{"key":"1578_CR10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts PJ, Targan SR et al (1999) Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 340:1398\u20131405","journal-title":"N Engl J Med"},{"key":"1578_CR11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN et al (2004) Infliximab maintenance therapy for fistulizing Crohn\u2019s disease. N Engl J Med 350:876\u2013885","journal-title":"N Engl J Med"},{"key":"1578_CR12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.gastro.2003.08.024","volume":"125","author":"American Gastroenterological Association Clinical Practice Committee","year":"2003","unstructured":"American Gastroenterological Association Clinical Practice Committee (2003) American Gastroenterological Association medical position statement: perianal Crohn\u2019s disease. Gastroenterology 125:1503\u20131507","journal-title":"Gastroenterology"},{"key":"1578_CR13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2036.2005.02670.x","volume":"22","author":"E Dom\u00e8nech","year":"2005","unstructured":"Dom\u00e8nech E, Hinojosa J, Nos P et al (2005) Clinical evolution of luminal and perianal Crohn\u2019s disease after inducing remission with infliximab: how long should patients be treated? Aliment Pharmacol Ther 22:1107\u20131113","journal-title":"Aliment Pharmacol Ther"},{"key":"1578_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/codi.13311","volume":"18","author":"EJ Groof De","year":"2016","unstructured":"De Groof EJ, Sahami S, Lucas C, Ponsioen CY, Bemelman WA, Buskens CJ (2016) A Treatment of perianal fistula in Crohn\u2019s disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal Dis 18:667\u2013675","journal-title":"Colorectal Dis"},{"key":"1578_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10350-004-6111-6","volume":"45","author":"A Bodegraven van","year":"2002","unstructured":"van Bodegraven A, Sloots C, Felt-Bersma R, Meuwissen S (2002) Endosonographic evidence of persistence of Crohn\u2019s disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 45:39\u201345","journal-title":"Dis Colon Rectum"},{"key":"1578_CR16","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","volume":"104","author":"CN Siew","year":"2009","unstructured":"Siew CN, Sophie P, Arun G et al (2009) Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn\u2019s perineal fistulas. Am J Gastroenterol 104:2973","journal-title":"Am J Gastroenterol"},{"key":"1578_CR17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","volume":"98","author":"G Assche Van","year":"2003","unstructured":"Van Assche G, Vanbeckevoort D, Bielen D et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn\u2019s disease. Am J Gastroenterol 98:332","journal-title":"Am J Gastroenterol"},{"key":"1578_CR18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/ibd.21940","volume":"18","author":"P Tozer","year":"2012","unstructured":"Tozer P, Ng SC, Siddiqui MR et al (2012) Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn\u2019s perianal fistulas. Inflamm Bowel Dis 18:1825\u20131834","journal-title":"Inflamm Bowel Dis"},{"key":"1578_CR19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","volume":"20","author":"RL West","year":"2004","unstructured":"West RL, van der Woude CJ, Hansen BE et al (2004) Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn\u2019s disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 20:1329\u20131336","journal-title":"Aliment Pharmacol Ther"},{"key":"1578_CR20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/apt.12906","volume":"40","author":"NA Yassin","year":"2014","unstructured":"Yassin NA, Askari A, Warusavitarne J et al (2014) Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn\u2019s disease. Aliment Pharmacol Ther 40:741\u2013749","journal-title":"Aliment Pharmacol Ther"},{"key":"1578_CR21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/apt.12928","volume":"40","author":"C Dupont-Lucas","year":"2014","unstructured":"Dupont-Lucas C, Dabadie A, Alberti C, Ruemmele FM, Pediatrique G (2014) Predictors of response to infliximab in paediatric perianal Crohn\u2019s disease. Aliment Pharmacol Ther 40:917\u2013929","journal-title":"Aliment Pharmacol Ther"},{"key":"1578_CR22","unstructured":"Eglinton TW (2012) Perianal Crohn\u2019s Disease in Canterbury, New Zealand (Thesis, Master of Medical Science). University of Otago"},{"key":"1578_CR23","first-page":"297","volume":"7","author":"S Renna","year":"2012","unstructured":"Renna S, Orlando A, Cottone M (2012) Randomized controlled trials in perianal Crohn\u2019s disease. Rev Recent Clin Trials 7:297\u2013302","journal-title":"Rev Recent Clin Trials"},{"key":"1578_CR24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ibd.20826","volume":"15","author":"A Losco","year":"2009","unstructured":"Losco A, Vigano C, Conte D, Cesana BM, Basilisco G (2009) Assessing the activity of perianal Crohn\u2019s disease: comparison of clinical indices and computer-assisted anal ultrasound. Inflamm Bowel Dis 15:742\u2013749","journal-title":"Inflamm Bowel Dis"},{"key":"1578_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2036.2010.04486.x","volume":"33","author":"PJ Tozer","year":"2011","unstructured":"Tozer PJ, Burling D, Gupta A, Phillips RKS, Hart AL (2011) Review article: medical, surgical and radiological management of perianal Crohn\u2019s fistulas. Aliment Pharmacol Ther 33:5\u201322","journal-title":"Aliment Pharmacol Ther"},{"key":"1578_CR26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2036.2009.04027.x","volume":"30","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Diamond RH, Wagner CL et al (2009) Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials. Aliment Pharmacol Ther 30:210\u2013226","journal-title":"Aliment Pharmacol Ther"},{"key":"1578_CR27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13063-015-0831-x","volume":"20","author":"EJ Groof de","year":"2015","unstructured":"de Groof EJ, Buskens CJ, Ponsioen CY et al (2015) Multimodal treatment of perianal fistulas in Crohn\u2019s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial. Trials 20:366","journal-title":"Trials"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-016-1578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-016-1578-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-016-1578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:37:10Z","timestamp":1498376230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-016-1578-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1578"],"URL":"https:\/\/doi.org\/10.1007\/s10151-016-1578-4","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}